Risk of Reactivation of Latent Pathogens Associated with Six-Monthly Rituximab Therapy in Children with Nephrotic Syndrome: A Retrospective Cohort Study

Ning Lan(First Affiliated Hospital of Xi'an Jiaotong University), Gaofu Zhang(China International Science and Technology Cooperation), Ximing Xu(Shanghai Changzheng Hospital), Cong Liu(Chinese Academy of Sciences), Jie Liu(Capital Medical University), Lu Tang(Children's Hospital of Chongqing Medical University)
Research Square
December 1, 2025
10.21203/rs.3.rs-8155025/v1
Cited by 0

Related Papers

Hepatogastroenterology
|Hepatogastroenterology|2012|1.8k
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
|Scientific Reports|2019|426
Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation
|Cell|2020|274
Quercetin as a tyrosinase inhibitor: Inhibitory activity, conformational change and mechanism
|Food Research International|2017|257
Evaluation of ChatGPT-generated medical responses: A systematic review and meta-analysis
|Journal of Biomedical Informatics|2024|181